Minerva Neurosciences Inc (NERV)

NASDAQ HEALTHCARE

$4.47 +6.68% RSI 39 Neutral Add Alert

Moving Averages

SMA 200

$4.62

Price below

Company Profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products for the treatment of diseases of the central nervous system. The company is headquartered in Waltham, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$215.24M

P/E Ratio

None

EPS

$-37.03

Beta

-0.169